Tapewire

Nasdaq · USD

JAZZ

Jazz Pharmaceuticals plc

Export transactions ↓
Tapewire entity
818
SEC CIK
0001232524
Parsed reports
624

Last 12 months

Inside the activity.

0 purchase rows · 59 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025013
Dec 202503
Jan 202600
Feb 2026015
Mar 202604
Apr 202603
May 202605
Jun 202603
Jul 202601
Aug 202607
Sep 202603
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 6, 2024 00:58 UTC
Henderson Mary ElizabethSVP, Technical Operations
GrantOrdinary Shares 5,178 $0.00 $0.00
Disclosure

SEC source: 0001765581-24-000026 · edgardoc.xml · nonDerivative · entry 1

Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,941

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:54 UTC
Carr PatriciaSVP, Chief Accounting Officer
GrantOrdinary Shares 2,987 $0.00 $0.00
Disclosure

SEC source: 0001765581-24-000024 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,300

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:50 UTC
Patil Neena MEVP & Chief Legal Officer
GrantOrdinary Shares 12,348 $0.00 $0.00
Disclosure

SEC source: 0001765581-24-000020 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,061

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:44 UTC
GALA RENEE DPresident & COO
GrantOrdinary Shares 19,916 $0.00 $0.00
Disclosure

SEC source: 0001765581-24-000015 · edgardoc.xml · nonDerivative · entry 1

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,715

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 00:34 UTC
COZADD BRUCE CDirector · Chairman & CEO
GrantOrdinary Shares 50,187 $0.00 $0.00
Disclosure

SEC source: 0001765581-24-000013 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 452,245

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:33 UTC
Pearce SamanthaSVP, Head of Europe & Internat
Tax withholdingOrdinary Shares 1,038 $119.13 $123,656.94
Disclosure

SEC source: 0001784606-24-000012 · edgardoc.xml · nonDerivative · entry 2

Pearce Samantha · CIK 0001805688 · SVP, Head of Europe & Internat

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,331

F2 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:33 UTC
Pearce SamanthaSVP, Head of Europe & Internat
GrantOrdinary Shares 2,210 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000012 · edgardoc.xml · nonDerivative · entry 1

Pearce Samantha · CIK 0001805688 · SVP, Head of Europe & Internat

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,369

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:25 UTC
Iannone RobertEVP, Global Head of R&D
Tax withholdingOrdinary Shares 1,730 $119.13 $206,094.90
Disclosure

SEC source: 0001784606-24-000008 · edgardoc.xml · nonDerivative · entry 2

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,592

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:25 UTC
Iannone RobertEVP, Global Head of R&D
GrantOrdinary Shares 5,970 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000008 · edgardoc.xml · nonDerivative · entry 1

Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,322

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:28 UTC
Patil Neena MEVP & Chief Legal Officer
Tax withholdingOrdinary Shares 1,656 $119.13 $197,279.28
Disclosure

SEC source: 0001784606-24-000010 · edgardoc.xml · nonDerivative · entry 2

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,713

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:28 UTC
Patil Neena MEVP & Chief Legal Officer
GrantOrdinary Shares 5,087 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000010 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,369

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 96 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:23 UTC
GALA RENEE DPresident & COO
Tax withholdingOrdinary Shares 3,204 $119.13 $381,692.52
Disclosure

SEC source: 0001784606-24-000006 · edgardoc.xml · nonDerivative · entry 2

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,799

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:23 UTC
GALA RENEE DPresident & COO
GrantOrdinary Shares 7,079 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000006 · edgardoc.xml · nonDerivative · entry 1

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,003

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:21 UTC
COZADD BRUCE CDirector · Chairman & CEO
Tax withholdingOrdinary Shares 12,245 $119.13 $1,458,746.85
Disclosure

SEC source: 0001784606-24-000004 · edgardoc.xml · nonDerivative · entry 2

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,058

F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:21 UTC
COZADD BRUCE CDirector · Chairman & CEO
GrantOrdinary Shares 26,545 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000004 · edgardoc.xml · nonDerivative · entry 1

COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,303

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 137 ordinary shares and 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 31, 2023 and November 30, 2023, respectively.

Read SEC document
January 17, 2024 Filed Jan 19, 2024 23:19 UTC
Carr PatriciaSVP, Chief Accounting Officer
GrantOrdinary Shares 1,327 $0.00 $0.00
Disclosure

SEC source: 0001784606-24-000002 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,363

F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.

F2 · balance_after: The Reporting Person acquired 50 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.

Read SEC document
December 04, 2023 Filed Dec 6, 2023 21:39 UTC SaleOrdinary Shares 417 $119.27 $49,735.59
Disclosure

SEC source: 0001765581-23-000110 · edgardoc.xml · nonDerivative · entry 1

Smith Mark Douglas · CIK 0001756253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,888

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
December 04, 2023 Filed Dec 6, 2023 21:31 UTC SaleOrdinary Shares 417 $119.27 $49,735.59
Disclosure

SEC source: 0001765581-23-000108 · edgardoc.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,888

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Read SEC document
December 04, 2023 Filed Feb 13, 2024 00:29 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 50 $121.39 $6,069.74
Disclosure

SEC source: 0001784606-24-000014 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,986

Read SEC document
November 10, 2023 Filed Nov 14, 2023 22:50 UTC
GALA RENEE DPresident & COO
GrantOrdinary Shares 772 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000106 · edgardoc.xml · nonDerivative · entry 1

GALA RENEE D · CIK 0001607737 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,887

F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of December 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

F2 · balance_after: Includes 137 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2023.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 21:09 UTC
Patil Neena MEVP & Chief Legal Officer
SaleOrdinary Shares 1,500 $144.25 $216,375.00
Disclosure

SEC source: 0001765581-23-000104 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,186

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2023.

Read SEC document
August 29, 2023 Filed Aug 31, 2023 22:44 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 142 $143.47 $20,372.54
Disclosure

SEC source: 0001765581-23-000102 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,986

Read SEC document
August 15, 2023 Filed Aug 17, 2023 21:21 UTC
Patil Neena MEVP & Chief Legal Officer
SaleOrdinary Shares 750 $139.59 $104,694.98
Disclosure

SEC source: 0001765581-23-000100 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,686

F1 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $139.56 to $139.63. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:58 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.20
Disclosure

SEC source: 0001765581-23-000088 · edgardoc.xml · nonDerivative · entry 2

RIEDEL NORBERT G · CIK 0001161662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,705

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.68 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:52 UTC SaleOrdinary Shares 1,344 $138.16 $185,685.16
Disclosure

SEC source: 0001765581-23-000084 · edgardoc.xml · nonDerivative · entry 2

McSharry Heather Ann · CIK 0001576068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,778

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 23:51 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.08
Disclosure

SEC source: 0001765581-23-000098 · edgardoc.xml · nonDerivative · entry 2

ORiordan Anne · CIK 0001767870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,551

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.67 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 23:49 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.70
Disclosure

SEC source: 0001765581-23-000096 · edgardoc.xml · nonDerivative · entry 2

O'Keefe Kenneth W · CIK 0001397661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,723

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 22:08 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.57
Disclosure

SEC source: 0001765581-23-000094 · edgardoc.xml · nonDerivative · entry 2

Winningham Rick E · CIK 0001302443 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,444

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 22:00 UTC SaleOrdinary Shares 1,241 $138.16 $171,453.95
Disclosure

SEC source: 0001765581-23-000090 · edgardoc.xml · nonDerivative · entry 2

Smith Mark Douglas · CIK 0001756253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,305

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.63 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 22:02 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.70
Disclosure

SEC source: 0001765581-23-000092 · edgardoc.xml · nonDerivative · entry 2

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,868

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:47 UTC
Gray PeterDirector
SaleOrdinary Shares 1,241 $138.16 $171,454.57
Disclosure

SEC source: 0001765581-23-000080 · edgardoc.xml · nonDerivative · entry 2

Gray Peter · CIK 0001576096 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,068

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.75 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:44 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.20
Disclosure

SEC source: 0001765581-23-000076 · edgardoc.xml · nonDerivative · entry 2

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,305

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.69 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:45 UTC SaleOrdinary Shares 1,241 $138.16 $171,454.70
Disclosure

SEC source: 0001765581-23-000078 · edgardoc.xml · nonDerivative · entry 2

ENRIGHT PATRICK G · CIK 0001253886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,946

F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F3 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 14, 2023 Filed Aug 15, 2023 21:43 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 158 $138.16 $21,828.89
Disclosure

SEC source: 0001765581-23-000074 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,128

F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:58 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000088 · edgardoc.xml · nonDerivative · entry 1

RIEDEL NORBERT G · CIK 0001161662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,946

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:52 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000084 · edgardoc.xml · nonDerivative · entry 1

McSharry Heather Ann · CIK 0001576068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,122

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:51 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000098 · edgardoc.xml · nonDerivative · entry 1

ORiordan Anne · CIK 0001767870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,792

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 23:49 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000096 · edgardoc.xml · nonDerivative · entry 1

O'Keefe Kenneth W · CIK 0001397661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,964

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 22:08 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000094 · edgardoc.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,685

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 22:00 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000090 · edgardoc.xml · nonDerivative · entry 1

Smith Mark Douglas · CIK 0001756253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,546

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 22:02 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000092 · edgardoc.xml · nonDerivative · entry 1

Sohn Catherine A. · CIK 0001555132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,109

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:56 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000086 · edgardoc.xml · nonDerivative · entry 1

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,172,375

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:49 UTC
Henderson Mary ElizabethSVP, Technical Operations
GrantOrdinary Shares 10,763 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000082 · edgardoc.xml · nonDerivative · entry 1

Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,763

F1 · kind: These restricted stock units are granted pursuant to the Issuer's GW Pharmaceuticals Long Term Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of September 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:47 UTC
Gray PeterDirector
GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000080 · edgardoc.xml · nonDerivative · entry 1

Gray Peter · CIK 0001576096 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,309

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:44 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000076 · edgardoc.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,546

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 21:45 UTC GrantOrdinary Shares 3,075 $0.00 $0.00
Disclosure

SEC source: 0001765581-23-000078 · edgardoc.xml · nonDerivative · entry 1

ENRIGHT PATRICK G · CIK 0001253886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,187

F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.

Read SEC document
August 07, 2023 Filed Aug 9, 2023 20:19 UTC
Patil Neena MEVP & Chief Legal Officer
Disposition to issuerOrdinary Shares 1,390 $131.51 $182,798.90
Disclosure

SEC source: 0001765581-23-000054 · edgardoc.xml · nonDerivative · entry 1

Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,436

F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 20:47 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,500 $0.00 Strike: $81.76 $0.00
Disclosure

SEC source: 0001765581-23-000052 · edgardoc.xml · derivative · entry 2

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 4,500 shares

Expires 2023-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This non-qualified stock option was granted on August 8, 2013 and vested over a period of one year from September 1, 2013. The options were fully vested as of August 1, 2014.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 20:47 UTC Exercise / conversionOrdinary Shares 4,500 $81.76 $367,920.00
Disclosure

SEC source: 0001765581-23-000052 · edgardoc.xml · nonDerivative · entry 1

Mulligan Seamus · CIK 0001536639 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,169,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:55 UTC
Carr PatriciaSVP, Chief Accounting Officer
SaleOrdinary Shares 126 $127.92 $16,117.42
Disclosure

SEC source: 0001765581-23-000050 · edgardoc.xml · nonDerivative · entry 1

Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,286

F1 · balance_after: The Reporting Person acquired 126 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 31, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.